Federal Register / Vol. 69, No. 185 / Friday, September 24, 2004 / Notices 57327

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

into the building by non-government 

employees. Persons without a government 

I.D. will need to show a photo I.D. and sign 

in at the security desk upon entering the 

building. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.nih.gov/od/oar/index.htm, where an 

agenda and any additional information for 

the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS)

Dated: September 17, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–21447 Filed 9–23–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Cancer 

Institute Initial Review Group, Subcommittee 

G–Education, Review of K01, K05, K07, K22, 

K23 and K24 Applications. 

Date: October 26–27, 2004. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Suites Alexandria, 601 

North Saint Asaph Street, Alexandria, VA 

22314. 

Contact Person: Ilda M. McKenna, 

Scientific Review Administrator, Research 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Boulevard, Room 

8111, Bethesda, MD 20892, (301) 496–7481, 

mckennai@mail.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS)

Dated: September 16, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–21439 Filed 9–23–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center For Complementary & 

Alternative Medicine; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; Db–16 Basic 

Science. 

Date: October 18–19, 2004. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Dale L. Birkle, PhD, 

Scientific Review Administrator, NIH/

NCCAM, 6707 Democracy Blvd., Democracy 

Two Building, Suite 401, Bethesda, MD 

20892, (301) 451–6570, birkled@mail.nih.gov.

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; JH–05 Clinical 

Science. 

Date: October 25–26, 2004. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Jeanette M. Hosseini, 

Scientific Review Administrator, National 

Center for Complementary and Alternative 

Medicine, 6707 Democracy Blvd., Suite 401, 

Bethesda, MD 20892, (301) 594–9096.

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel. 

Date: November 3–5, 2004. 

Time: 6 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Premier at Tyson’s Corner, 

8661 Leesburg Pike, Vienna, VA 22182. 

Contact Person: Dale L. Birkle, PhD, 

Scientific Review Administrator, NIH/

NCCAM, 6707 Democracy Blvd., Democracy 

Two Building, Suite 401, Bethesda, MD 

20892, (301) 451–6570, birkled@mail.nih.gov.

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; CP–18 Training. 

Date: November 5, 2004. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Carol Pontzer, PhD, 

Scientific Review Administrator, National 

Center for Complementary and Alternative 

Medicine, 6707 Democracy Blvd., Bethesda, 

MD 20892.

Dated: September 10, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–21436 Filed 9–23–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

57328 Federal Register / Vol. 69, No. 185 / Friday, September 24, 2004 / Notices 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel, ZAA1 HH (06)—Review of 

U18 Applications. 

Date: October 22, 2004. 

Time: 2 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Fishers, 5635 Fishers Lane, Room 3033, 

Bethesda, MD 20892 (Telephone conference 

call). 

Contact Person: Jeffrey I. Toward, PhD, 

Scientific Review Administrator, National 

Institutes of Health, National Institute on 

Alcohol Abuse and Alcoholism, Extramural 

Project Review Branch, OSA, 5635 Fishers 

Lane, Bethesda, MD 20892–9304. (301) 435–

5337; jtoward@mail.nih.gov.

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel, ZAA1 EE (01)—Fellowship 

Application Review. 

Date: November 17, 2004. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The River Inn, 924 25th Street, 

N.W., Washington, DC 20037. 

Contact Person: Dorita Sewell, PhD, 

Scientific Review Administrator, National 

Institutes of Health, National Institute on 

Alcohol Abuse and Alcoholism, Office of 

Extramural Research, 5635 Fishers Lane, 

Bethesda, MD 20892–9304. (301) 443–2890; 

dsewell@mail.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants, 

National Institutes of Health, HHS.)

Dated: September 17, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–21428 Filed 9–23–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel, ZAA1 HH (03)—Review of 

U18 Applications. 

Date: October 13, 2004. 

Time: 2 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Fishers 

Building, 5635 Fishers Lane, Room 3033, 

Bethesda, MD 20892 (Telephone conference 

call). 

Contact Person: Jeffrey I. Toward, PhD, 

Scientific Review Administrator, National 

Institutes of Health, National Institute on 

Alcohol Abuse and Alcoholism, Extramural 

Project Review Branch, OSA, 5635 Fishers 

Lane, Bethesda, MD 20892–9304. (301) 435–

5337. jtoward@mail.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants, 

National Institutes of Health, HHS)

Dated: September 17, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–21429 Filed 9–23–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Initial 

Review Group, Clinical and Treatment 

Subcommittee, AA–3. 

Date: October 28–29, 2004. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Double Tree Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Mahadev Murthy, PhD, 

MBA, Scientific Review Administrator, 

Extramural Project Review Branch, Office of 

Scientific Affairs, National Institute on 

Alcohol Abuse and Alcoholism, MSC 9304, 

Room 3037, Bethesda, MD 20892–9304. (301) 

443–0800; mmurthy@mail.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants, 

National Institutes of Health, HHS)

Dated: September 17, 2004. 

Laverne Y. Stringfield 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–21430 Filed 9–23–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Child Health and 

Human Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel, Regulation of 

Estradiol Production of Prostaglandin 

F2alpha. 

Date: October 14, 2004. 

Time: 2 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Room 5B01, Rockville, 

MD 20852. (Telephone conference call).